3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
4
Breast Neoplasms
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Esophageal Neoplasms
2
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Ovarian Neoplasms
1
Metastatic Hormone-sensitive Prostate Cancer
1
Metastatic Castration Resistant Prostate Cancer
1
Fallopian Tube Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Interventions
pembrolizumab
4
Nivolumab
4
trametinib
2
relatlimab
2
larotrectinib
2
dabrafenib
2
binimetinib
2
Vemurafenib
2
Ipilimumab
2
ulixertinib
1
trastuzumab biosimilar HLX02
1
sapanisertib
1
pertuzumab
1
palbociclib
1
osimertinib
1
omipalisib
1
ipatasertib
1
erdafitinib
1
entrectinib
1
encorafenib
1
defactinib
1
copanlisib
1
cobimetinib
1
capivasertib
1
atezolizumab
1
adavosertib
1
X-Rays
1
Trastuzumab
1
Sunitinib
1
Specimen Handling
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has announcements
×
Melanoma
×
Docetaxel
×
Clear all
No trials found.